CEDER MED s.r.o.Active
Key figures
Key figures
2023Balance sheet structure
Summary of annual reports2020–2023
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Revenue (net turnover) | 26 661 | 25 538 | 38 800 | 47 813 |
| Profit for the reporting year | -8 074 | -2 641 | -15 156 | -5 590 |
| Retained earnings of previous periods | -14 458 | -22 532 | -25 173 | -40 329 |
| Total assets | 37 397 | 36 970 | 77 909 | 77 427 |
| Total liabilities | 54 429 | 56 643 | 112 738 | 117 846 |
| Total equity | -17 032 | -19 673 | -34 829 | -40 419 |
| Calculated dividends | — | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Similar companies
Summary: CEDER MED s.r.o.
Overview
CEDER MED s.r.o. (IČO 50878638) is a limited liability company (s.r.o.). The company was incorporated in 2017 and has existed for 9 years. Registered office according to the register: Košice. Main activity according to the Statistical Office: výroba nealkoholických nápojov a fľaškových vôd (SK NACE 1107).
People
The company has one statutory representative. According to the register, the company has 2 shareholders. The registered capital is 5 000 €.
Financial results
Revenue for 2023 was 47 813 €, up 23,2 % on the previous year (38 800 €). From 2020 to 2023, revenue grew by an average of 21,5 % per year. This is the highest revenue in the reported years (2020–2023). 2023 ended with a loss of 5 590 €. The company made a loss in all 4 reported years. Personnel costs for 2023 were 22 153 €.
Points to note
Equity was negative at the end of 2023 (-40 419 €). The latest financial statement with structured data is for 2023.
Sources and freshness
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 7. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.